VA Premier CompleteCare Drugs that Require Step Therapy Last Updated: 09/23/2014



Similar documents
ACTEMRA. Step Therapy Criteria HEALTH CHOICE EXCHANGE 2016 Effective Date: 01/01/2016. PRODUCT(s) AFFECTED ACTEMRA

2014 Valley Baptist Medicare D Formulary Step Therapy Criteria

2015 Medicare Part D Step Therapy Requirements. Effective: November 01, 2015

MEDICATION(S) SUBJECT TO STEP THERAPY

Prescribing Pathway for Drug Treatment for Overactive Bladder.

AETNA BETTER HEALTH Prior Authorization guidelines for Step Therapy

this 7^ day of September 2014 by Randall S. Gregg Special Deputy Director

West Virginia Medicaid PDL Recommended Changes Summary Pharmaceutical and Therapeutics Committee Meeting January 26, 2011

Blueprint for Prescriber Continuing Education Program

Pain Management in Palliative and Hospice Care

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program

Pharmacy Management Drug Policy

Effective January 1, 2016

OPIOIDS CONVERSION GUIDELINES 2007

Prescription Drug Utilization and Cost Trends,

Narcotic drugs used for pain treatment Version 4.3

Department of Vermont Health Access Pharmacy Benefit Management Program DUR Board Meeting Minutes: 03/11/2014

Table 1 Performance Measures. Quality Monitoring P4P Yr1 Yr2 Yr3. Specification Source. # Category Performance Measure

Committee Approval Date: December 12, 2014 Next Review Date: December 2015

SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

APRIL 2015 THE 2014 DRUG TREND REPORT WORKERS COMPENSATION

Pain management. The WHO analgesic ladder

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

OFFICE OF THE ASSISTANT SECRETARY OF DEFENSE HEALTH AFFAIRS 7700 ARLINGTON BOULEVARD, SUITE 5101 FALLS CHURCH, VIRGINIA

612 Program Midtown Express Pharmacy

Acetylcholinesterase Inhibitors and Memantine Clinical Indication: Treatment of Dementia in Alzheimer s Disease (AD)

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Tysabri

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

UPDATED INVESTOR PRESENTATION June 2015

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC

Medication Policy Manual. Topic: Gilenya, fingolimod Date of Origin: November 22, 2010

ALASKA MEDICAID PHARMACY AND THERAPEUTICS COMMITTEE. Location of Meeting Frontier Building, 3601 C Street, room 890/896

Immune Modulating Drugs Prior Authorization Request Form

Hospice & Palliative Care in Developing Countries

Reducing Narcotics Misuse and Abuse in Workers Compensation

Growth in revenue from MS drugs has been driven largely by price increases over the last several years.

Drug Formulary Update, July 2013

PHARMACOLOGY UPDATE: BOOMER DRUGS

Patient Tools: What You Need to Know about Paying for Your Osteoporosis Medications. February Developed by the National Osteoporosis Foundation

STAT Bulletin. Drug Therapy Guideline Updates. May 11, 2012 Volume: 18 Issue: 12

Notice from the Executive Officer: Supporting Sustainability and Access for the Ontario Drug Benefit Program

Best Practices for Patients With Pain. Commonly Used Over the Counter (OTC) Pain Relievers 5/15/2015

Potential Savings from Generic Drugs in Upstate New York

Community Pharmacists in NHS Rotherham

Prescribed Drug Spending in Canada, 2013: A Focus on Public Drug Programs

Essential Shared Care Agreement Drugs for Dementia

Overall Drug Trends in. Artemis Emslie VP of Pharmacy Product Development

Where Can I Buy Alli Uk

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Insight. Drug Class. Background, new developments, key strategies. Introduction. Faulty signals. 400,000 patients in the US 1

Richard C. Dart, MD, PhD Denver Health & Hospital Authority Professor, University of Colorado School of Medicine

Alla chme nl A EFFECTIVE 07/01/2014 BUREAU FOR MEDICAL SERVICES WEST VIRGINIA MEDICAID PREFERRED DRUG LIST WITH PRIOR AUTHORIZATION CRITERIA

May 31, Ms. Debra Lansey American College of Physicians 190 North Independence Mall West Philadelphia, PA 19106

Indocin Pda Closure. indocin suppository storage. indocin 50mg. indocin tablets. indocin sr capsules. indocin headache treatment

Abstral Prescriber and Pharmacist Guide

Key Findings. Use this report to... The Autoimmune Market Outlook to 2013

Office of Medical Assistance (OMA) P&T Committee Meeting Minutes

Updates to the Alberta Human Services Drug Benefit Supplement

How To Get A Tirf

Disease Modifying Therapies for MS

UNIT VIII NARCOTIC ANALGESIA

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

If your drug is not on the list just give us a call for a price. Ask us for details on how to avoid the higher deductible generic price.

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

Preferred Drug List Updates Effective: Jan. 1, 2016

PROJECT LIST GENERIC PRODUCTS

OVERACTIVE BLADDER DIAGNOSIS AND TREATMENT OF OVERACTIVE BLADDER IN ADULTS:

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist

PHARMACEUTICAL MANAGEMENT PROCEDURES

Lora McGuire MS, RN Educator and Consultant Barriers to effective pain relief

Cancer Pain Role Model Program Case Studies and Faculty Guides. Wisconsin Cancer Pain Initiative Madison, Wisconsin

Lemtrada (alemtuzumab)

Global Multiple Sclerosis Market: Trends and Opportunities ( )

Policy for the issue of permits to prescribe Schedule 8 poisons

Drug Formulary Update, July 2014 Commercial and State Programs

Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS?

Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010

A Healthesystems Clinical Analysis. Insidious Incrementalism of Opioid Use in Workers Compensation

Extra Value Drug List. *

Opioid Analgesics. Week 19

Opioid Conversion Ratios - Guide to Practice 2013

MUSC Opioid Analgesic Comparison Chart

Multiple Sclerosis Therapeutics to Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth

Disease Modifying Therapies for MS

Medication Policy Manual. Topic: Plegridy, peginterferon beta-1a Date of Origin: December 12, 2014

Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company

What is Multiple Sclerosis? Gener al information

National Multiple Sclerosis Society. Disease Modification in Multiple Sclerosis. Current as of January 2, 2013

AGENDA. State and Public School Life and Health Insurance Board 01/30/ :00 p.m. EBD Board Room 501 Building, Suite 500

Transcription:

Atelvia Atelvia Claim will pay automatically for Atelvia if enrollee has a paid claim for at least a 1 days supply of alendronate in the past 365 days. Otherwise, Atelvia requires a step therapy exception request indicating: (1) history of inadequate treatment response with alendronate, OR (2) history of adverse event with alendronate, OR (3) alendronate is contraindicated. Effective Date: 10/01/2014 Page 1 of 14

Aubagio Aubagio Claim will pay automatically for aubagio if enrollee has a paid claim for at least a 1 days supply of MITOXANTRONE, REBIF, COPAXONE, or Betaseron in the past 365 days. Otherwise, aubagio requires a step therapy exception request indicating: (1) history of inadequate treatment response with MITOXANTRONE, REBIF, COPAXONE, or Betaseron, OR (2) history of adverse event with MITOXANTRONE, REBIF, COPAXONE, or Betaseron, OR (3) MITOXANTRONE, REBIF, COPAXONE, or Betaseron is contraindicated. Effective Date: 10/01/2014 Page 2 of 14

Brintellix Brintellix Claim will pay automatically for brintellix if enrollee has a paid claim for at least a 1 days supply of any 2 generic formulary antidepressants in the past 365 days. Otherwise, brintellix requires a step therapy exception request indicating: (1) history of inadequate treatment response with any 2 generic formulary antidepressants, OR (2) history of adverse event with any 2 generic formulary antidepressantss, OR (3) any 2 generic formulary antidepressants are contraindicated. Effective Date: 10/01/2014 Page 3 of 14

Celebrex Celebrex Claim will pay automatically for Celebrex if enrollee has a paid claim for at least a 1 days supply of Generic NSAID tablets or capsules in the past 365 days. Otherwise, Celebrex requires a step therapy exception request indicating: (1) history of inadequate treatment response with oral NSAIDs, OR (2) history of adverse event with oral NSAIDs, OR (3) oral NSAIDs are contraindicated. Effective Date: 10/01/2014 Page 4 of 14

Dexilant Dexilant Claim will pay automatically for Dexilant if enrollee has a paid claim for at least a 1 days supply of omeprazole or pantoprazole in the past 365 days. Otherwise, Dexilant requires a step therapy exception request indicating: (1) history of inadequate treatment response with omeprazole or pantoprazole, OR (2) history of adverse event with omeprazole or pantoprazole, OR (3) omeprazole or pantoprazole is contraindicated. Effective Date: 10/01/2014 Page 5 of 14

Dificid Dificid Claim will pay automatically for Dificid if enrollee has a paid claim for at least a 1 days supply of Generic Vancomycin capsules in the past 120 days. Otherwise, Dificid requires a step therapy exception request indicating: (1) history of inadequate treatment response with Vancomycin, OR (2) history of adverse event with Vancomycin, OR (3) Vancomycin is contraindicated. Effective Date: 10/01/2014 Page 6 of 14

Edari Edarbi Claim will pay automatically for Edarbi if enrollee has a paid claim for at least a 1 days supply of losartan in the past 365 days. Otherwise, Edarbi requires a step therapy exception request indicating: (1) history of inadequate treatment response with losartan, OR (2) history of adverse event with losartan, OR (3) losartan is contraindicated. Effective Date: 10/01/2014 Page 7 of 14

Edarychlor Edarbyclor Claim will pay automatically for Edarbychlor if enrollee has a paid claim for at least a 1 days supply of losartan/hctz or Edarbi in the past 365 days. Otherwise, Edarbychlor requires a step therapy exception request indicating: (1) history of inadequate treatment response with losartan/hctz or Edarbi, OR (2) history of adverse event with losartan/hctz or Edarbi, OR (3) losartan/hctz or Edarbi is contraindicated. Effective Date: 10/01/2014 Page 8 of 14

Enablex Enablex Claim will pay automatically for Enablex if enrollee has a paid claim for at least a 1 days supply of any generic formulary urinary anticholinergic in the past 365 days. Otherwise, Enablex requires a step therapy exception request indicating: (1) history of inadequate treatment response with generic formulary urinary anticholinergic, OR (2) history of adverse event with generic formulary urinary anticholinergic, OR (3) generic formulary urinary anticholinergic is contraindicated. Effective Date: 10/01/2014 Page 9 of 14

Fentanyl Fentanyl Transdermal Patch Claim will pay automatically for Fentanyl patches if enrollee has paid claims history for both Group A and Group B drugs. GROUP A Drugs: Any 1 days supply in the past 365 days of generic Oxymorphone ER (2) GROUP B Drugs: Any 1 days supply in the past 365 days of either Morphine ER or Methadone. Otherwise, the drug requires a step therapy exception request indicating any ONE of the following: (1) history of inadequate treatment response with Group A or Group B drugs, OR (2) history of adverse event with Group A or Group B drugs, OR (3) Group A or Group B drugs are contraindicated. Effective Date: 10/01/2014 Page 10 of 14

High Potency Statin Crestor Patient needs to have a paid claim for a Step 1 drug (atorvastatin) prior to filling a Step 2 drug (Crestor). Effective Date: 10/01/2014 Page 11 of 14

Myrbetriq Myrbetriq Claim will pay automatically for Myrbetriq if enrollee has a paid claim for at least a 1 days supply of any formulary urinary anticholinergic in the past 365 days. Otherwise, Myrbetriq requires a step therapy exception request indicating: (1) history of inadequate treatment response with formulary urinary anticholinergic, OR (2) history of adverse event with formulary urinary anticholinergic, OR (3) formulary urinary anticholinergic is contraindicated. Effective Date: 10/01/2014 Page 12 of 14

Uceris Uceris Claim will pay automatically for Uceris if enrollee has a paid claim for at least a 1 days supply of any formulary corticosteroid used to treat ulcerative colitis in the past 365 days. Otherwise, Uceris requires a step therapy exception request indicating: (1) history of inadequate treatment response with formulary corticosteroid used to treat ulcerative colitis, OR (2) history of adverse event with formulary corticosteroid used to treat ulcerative colitis, OR (3) formulary corticosteroid used to treat ulcerative colitis is contraindicated. Effective Date: 10/01/2014 Page 13 of 14

Uloric Uloric Claim will pay automatically for Uloric if enrollee has a paid claim for at least a 1 days supply of Allopurinol in the past 365 days. Otherwise, Uloric requires a step therapy exception request indicating: (1) history of inadequate treatment response with Allopurinol, OR (2) history of adverse event with Allopurinol, OR (3) Allopurinol is contraindicated. Effective Date: 10/01/2014 Page 14 of 14